Background Several studies including two meta-analyses have showed that delay between
surgery and adjuvant chemotherapy adversely impacts colorectal cancer survival. This study …

Purpose To evaluate factors affecting the use and delay≥ 8 weeks of adjuvant
chemotherapy and the impact of chemotherapy use and delay on survival. Methods …

Aim Reoperation after elective colorectal resection may delay the start of adjuvant
chemotherapy (AC). The study investigated the dual impact of a reoperation and AC delay …

BACKGROUND: Several reports suggest that the efficacy of adjuvant chemotherapy on
survival diminishes over time for colon cancer; however, precise timing of its loss of benefit …

BACKGROUND: In stage III colorectal cancer (CRC), adjuvant chemotherapy (CT) is usually
prescribed within two months after curative surgery. Whether or not delaying initiation of CT …

Aim Delay in commencing adjuvant therapy for colorectal cancer seems to impair survival in
some retrospective studies. This study was planned to evaluate its impact on survival …

Context Adjuvant chemotherapy (AC) improves survival among patients with resected
colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown …

Surgery remains the only curative therapy for colorectal cancer (CRC); however, several
studies have proved that adjuvant chemotherapy improves the curative rate. A growing body …

Background Postoperative adjuvant chemotherapy (AC) is now well-accepted as standard
for high-risk stage II and stage III colorectal cancer (CRC) patients, however the optimal time …

Background There is a paucity of literature quantifying the extent to which time to adjuvant
chemotherapy for stage III colon cancer patients varies between individual surgeons …